GlaxoSmithKline (GSK.L: Quote, Profile, Research, Stock Buzz) expects to record a legal charge of 1.57 billion pounds ($2.4 billion) for the second quarter after settling the "substantial majority" of claims relating to its controversial diabetes pill Avandia.
Thursday, July 15, 2010
Glaxo Takes $2.4 Bln Charge, Avandia Mostly Settled
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment